Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The Dow Jones Industrial Average, a longtime bellwether for the U.S. economy, flirted yesterday with a high-water mark not seen since Lehman Brothers’ collapse triggered an economic implosion more than 4 years ago.
A newly uncovered Johnson & Johnson (NYSE:JNJ) email may pose problems for the health care giant in the ongoing lawsuits over defunct hip implants made by subsidiary DePuy Orthopaedics.
Although his 10-year tenure at the helm of Johnson & Johnson (NYSE:JNJ) is likely to be remembered for the spate of recalls that have bedeviled the health care giant for the past few years, William Weldon should also be remembered for something he didn’t do: Spend billions on a buyout of pacemaker company Guidant Corp.